2023-09-05 06:00:00
Philippe Lamoureux, managing director of Leem, an organization representing pharmaceutical companies, insists on the importance of raising the price of old drugs to avoid future shortages.
Philippe Lamoureux is the Managing Director of Entreprises duMedicine (Leem), the professional organization of pharmaceutical laboratories.
LE FIGARO. – The government is working on a revaluation of 10 % of the prices of certain drugs. Are prices the answer to shortages ?
Philippe LAMOUREUX. – This will not solve everything, because drug shortages are multifactorial. It is enough for a supplier of raw materials to close in Asia, for the Chinese authorities to modify their recommendations on the management of a pathology or for a manufacturer of biological drugs to find themselves faced with non-compliant batches that must be destroyed. , for example, to create tensions throughout the supply chain. The fact remains that France has prices that are among the lowest in Europe and that this weakens the conditions for the exploitation of drugs. We no longer have priority in the allocation of stocks in the event of supply tensions.
Read alsoPirola and Eris variants, vaccination, tests: the great return of Covid-19
Raising prices allows…
This article is for subscribers only. You have 83% left to discover.
Want to read more?
Unlock all items immediately.
Already subscribed? Login
#Europe #France #longer #priority #allocation #drug #stocks